Editorial: Hot topics in diabetes and steatotic liver disease
Non-alcoholic fatty liver disease (NAFLD), currently reframed as metabolic dysfunction-associated steatotic liver disease (MASLD), is one of the most prevalent...
Diabetes
When Diabetes Comes for the Kidneys, Blood Chemistry Tells the Story First
One in three adults in Pakistan now has diabetes. That figure, confirmed by the World Health Organization last November, makes...
Superior renal benefits of SGLT2 inhibitors in type 2 diabetes highlighted in comparative study
Initiating treatment with a sodium–glucose cotransporter-2 (SGLT2) inhibitor rather than a glucagon-like peptide-1 receptor agonist (GLP-1RA) is associated with better...
Transforming Population Health for Diabetes and Kidney Disease via Systems of Excellence
Am J Manag Care. 2025;31(Spec. No. 10):SP724_____Health care leaders and physicians from University Hospitals convened at an Institute for Value-Based...
Chronic kidney disease in India 138 million affected rising prevalence poor diabetes control
When a disease grows silently, it’s easy to miss until it’s too late. That’s precisely what’s happening in India with...
Association of kidney function impairment with healthcare service utilisation in individuals with type 2 diabetes: an observational follow-up study in primary care | BMC Health Services Research
Main findingsIn this study, based on a mean follow-up time of 5.6 years, a kidney function impairment of 25% or...
